McCabe R T, de Costa B R, Miller R L, Havunjian R H, Rice K C, Skolnick P
Laboratory of Neuroscience, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
FASEB J. 1990 Aug;4(11):2934-40. doi: 10.1096/fasebj.4.11.2165950.
Fluorescein conjugates of the high-affinity benzodiazepine receptor ligands Ro 15-1788 and Ro 7-1986 were synthesized. The binding of these fluorescent ligands (BD 621 and BD 607) to benzodiazepine receptors was characterized by direct fluorescence measurement. Both the equilibrium dissociation constants (KD) of BD 621 and BD 607 and the maximum number of binding sites (Bmax) estimated by fluorescence monitoring were consistent with values obtained by using radioligand binding techniques. The binding of BD 621 and BD 607 assessed by fluorescence measurement was reversible, abolished by photoaffinity labeling with Ro 15-4513, and unaffected by a variety of substances that do not bind to benzodiazepine receptors. The potencies of chemically diverse benzodiazepine receptor compounds to inhibit fluorescent ligand binding were highly correlated (r = 0.94, P less than 0.001), with potencies obtained from radioligand binding techniques. These findings demonstrate the feasibility of using direct fluorescence measurement techniques to quantitate ligand-receptor interactions.
合成了高亲和力苯二氮䓬受体配体Ro 15 - 1788和Ro 7 - 1986的荧光素缀合物。通过直接荧光测量对这些荧光配体(BD 621和BD 607)与苯二氮䓬受体的结合进行了表征。通过荧光监测估计的BD 621和BD 607的平衡解离常数(KD)以及结合位点的最大数量(Bmax)与使用放射性配体结合技术获得的值一致。通过荧光测量评估的BD 621和BD 607的结合是可逆的,用Ro 15 - 4513进行光亲和标记可消除这种结合,并且不受多种不与苯二氮䓬受体结合的物质的影响。化学结构多样的苯二氮䓬受体化合物抑制荧光配体结合的效力与从放射性配体结合技术获得的效力高度相关(r = 0.94,P小于0.001)。这些发现证明了使用直接荧光测量技术定量配体 - 受体相互作用的可行性。